APA (7th ed.) Citation

Hainsworth, J. D., Infante, J. R., Spigel, D. R., Arrowsmith, E. R., Boccia, R. V., & Burris, H. A. (2011). A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma. Cancer Investigation, 29(7), 451. https://doi.org/10.3109/07357907.2011.590568

Chicago Style (17th ed.) Citation

Hainsworth, John D., Jeffrey R. Infante, David R. Spigel, Edward R. Arrowsmith, Ralph V. Boccia, and Howard A. Burris. "A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma." Cancer Investigation 29, no. 7 (2011): 451. https://doi.org/10.3109/07357907.2011.590568.

MLA (9th ed.) Citation

Hainsworth, John D., et al. "A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma." Cancer Investigation, vol. 29, no. 7, 2011, p. 451, https://doi.org/10.3109/07357907.2011.590568.